DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

359.92 1.00 (0.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

REGN $359.92 0.28%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $358.00
Previous Close $358.92
Daily Range $355.38 - $360.17
52-Week Range $257.69 - $369.31
Market Cap $36.4B
P/E Ratio 101.97
Dividend (Yield) $0.00 (0.0%)
Volume 743,787
Average Daily Volume 654,711
Current FY EPS $7.95





Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website:

News & Commentary

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

Sector Update: Health-Care Shares Mixed Pre-Market

Sector Update: Health Care

Regeneron Is Regenerating Growth In My Portfolio Once Again

UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Inc Following DME Doc Event

Friending Facebook To The Growth Portfolio In Replace Of Regeneron

Regeneron Gets Breakthrough Therapy Status for Eylea - Analyst Blog Daily Round Up 9/17/14: HTWR, REGN, IO, HALO

10 stocks for conservative investors who want to make a lot of money

Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

See More REGN News...

REGN's Top Competitors

REGN $359.92 (0.28%)
Current stock: REGN
AMGN $142.18 (-1.27%)
Current stock: AMGN
GILD $105.47 (-0.46%)
Current stock: GILD
BIIB $329.76 (0.16%)
Current stock: BIIB